Menu
Back to User profile » Professor Luca Gallelli
Papers published by Professor Luca Gallelli:
Role of p38 Mitogen-Activated Protein Kinase in Asthma and COPD: Pathogenic Aspects and Potential Targeted Therapies
Pelaia C, Vatrella A, Gallelli L, Lombardo N, Sciacqua A, Savino R, Pelaia G
Drug Design, Development and Therapy 2021, 15:1275-1284
Published Date: 23 March 2021
Glucocorticoid-Like Activity of Escin: A New Mechanism for an Old Drug
Gallelli L, Cione E, Wang T, Zhang L
Drug Design, Development and Therapy 2021, 15:699-704
Published Date: 24 February 2021
Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties
Gallelli L
Drug Design, Development and Therapy 2019, 13:3425-3437
Published Date: 27 September 2019
Add-on administration of ultramicronized palmitoylethanolamide in the treatment of new-onset burning mouth syndrome
Chirchiglia D, Chirchiglia P, Marotta R, Gallelli L
International Medical Case Reports Journal 2019, 12:39-42
Published Date: 15 February 2019
Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab
Pelaia C, Vatrella A, Busceti MT, Gallelli L, Terracciano R, Savino R, Pelaia G
Drug Design, Development and Therapy 2017, 11:3137-3144
Published Date: 30 October 2017
Theophylline action on primary human bronchial epithelial cells under proinflammatory stimuli and steroidal drugs: a therapeutic rationale approach
Gallelli L, Falcone D, Cannataro R, Perri M, Serra R, Pelaia G, Maselli R, Savino R, Spaziano G, D’Agostino B
Drug Design, Development and Therapy 2017, 11:265-272
Published Date: 23 January 2017
Role of biologics in severe eosinophilic asthma – focus on reslizumab
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Preianò M, Lombardo N, Terracciano R, Maselli R
Therapeutics and Clinical Risk Management 2016, 12:1075-1082
Published Date: 1 July 2016
Fondaparinux vs warfarin for the treatment of unsuspected pulmonary embolism in cancer patients
Amato B, Compagna R, Rocca A, Bianco T, Milone M, Sivero L, Vigliotti G, Amato M, Danzi M, Aprea G, Gallelli L, de Franciscis S, Serra R
Drug Design, Development and Therapy 2016, 10:2041-2046
Published Date: 23 June 2016
Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
Pelaia G, Vatrella A, Busceti MT, Gallelli L, Calabrese C, Terracciano R, Lombardo N, Maselli R
Therapeutics and Clinical Risk Management 2015, 11:1563-1572
Published Date: 8 October 2015
Aterofisiol® in carotid plaque evolution
Amato B, Compagna R, Amato M, Gallelli L, de Franciscis S, Serra R
Drug Design, Development and Therapy 2015, 9:3877-3884
Published Date: 23 July 2015
The effects of sulodexide on both clinical and molecular parameters in patients with mixed arterial and venous ulcers of lower limbs
Serra R, Gallelli L, Conti A, De Caridi G, Massara M, Spinelli F, Buffone G, Caliò FG, Amato B, Ceglia S, Spaziano G, Scaramuzzino L, Ferrarese AG, Grande R, de Franciscis S
Drug Design, Development and Therapy 2014, 8:519-527
Published Date: 13 May 2014